Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
AGC will invest a total of almost $20 million in biologics contract manufacturing facilities in the US and Denmark. The Japanese firm will add a 500 L mammalian cell bioreactor in Seattle and a purification line in Copenhagen. The projects are set to be completed next year. AGC, the former Asahi Glass, got the facilities in 2017, when it bought the Danish firm CMC Biologics as part of a push into the life sciences.
This article has been sent to the following recipient: